Teva Pharmaceutical Industries
TEVA
$13.81
Share price
4.23%
Change (1 day)
68.21%
Change (1 year)
Categories
Operating Margin for Teva Pharmaceutical Industries (TEVA)
Operating Margin as of April 2024 (TTM): -20.53%
According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current Operating Margin is -20.53%. At the end of 2022 the company had an Operating Margin of -20.54%.
Operating Margin history for Teva Pharmaceutical Industries from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -20.54% | -595.55% |
| 2021 | 4.14% | -115.67% |
| 2020 | -26.45% | 253.09% |
| 2019 | -7.49% | -45.6% |
| 2018 | -13.77% | -83.23% |
| 2017 | -82.10% | -2282.43% |
| 2016 | 3.76% | -68.57% |
| 2015 | 11.97% | -33.31% |
| 2014 | 17.95% | 191.64% |
| 2013 | 6.15% | -31.27% |
| 2012 | 8.95% | -44.54% |
| 2011 | 16.14% | -28.63% |
| 2010 | 22.62% | 42.69% |
| 2009 | 15.85% | 112.45% |
| 2008 | 7.46% | -70.17% |
| 2007 | 25.01% | 197.86% |
| 2006 | 8.40% | -66.31% |
| 2005 | 24.92% | 98.12% |
| 2004 | 12.58% | -52.75% |
| 2003 | 26.63% | 34.29% |
| 2002 | 19.83% | 20.49% |
| 2001 | 16.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -184.12% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | -268.58% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -188.70% | 🇫🇷 France |
 Merck MRK | 27.73% | -235.07% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -127.42% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 22.54% | -209.79% | 🇬🇧 UK |
 Dr. Reddy's RDY | 24.69% | -220.26% | 🇮🇳 India |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.